The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 06, 2018

Filed:

Mar. 22, 2017
Applicant:

Guerbet, Villepinte, FR;

Inventors:

Dominique Meyer, La Rochelle, FR;

Claire Corot, Lyons, FR;

Marc Port, Deuil la Barre, FR;

Vincent Barbotin, Montmorency, FR;

Bruno Bonnemain, Villeparisis, FR;

Assignee:

GUERBET, Villepinte, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/10 (2006.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); A61K 31/28 (2006.01); A61K 47/18 (2017.01); G01N 33/15 (2006.01);
U.S. Cl.
CPC ...
A61K 49/108 (2013.01); A61K 9/0019 (2013.01); A61K 31/28 (2013.01); A61K 45/06 (2013.01); A61K 47/18 (2013.01); A61K 49/106 (2013.01); G01N 33/15 (2013.01);
Abstract

The invention relates to a process for preparing a liquid pharmaceutical formulation containing a complex of macrocyclic chelate with a lanthanide and a mol/mol amount of free macrocyclic chelate of between 0.002% and 0.4%, advantageously between 0.02% and 0.3% and very advantageously between 0.025% and 0.25%, the macrocyclic chelate advantageously being chosen from DOTA, NOTA, DOTAGA, D03A, BT-D03A, HP-D03A and PCTA, and is preferably DOTA, the said process comprising the following successive steps: b) preparation of a liquid pharmaceutical composition containing, firstly, the complex of macrocyclic chelate with a lanthanide, and, secondly, free macrocyclic chelate and/or free lanthanide; c) measurement in the pharmaceutical formulation obtained in step b) of the concentration of free macrocyclic chelate Cchl and/or of free lanthanide Ciani; d) adjustment of Cchl and/or of Ciani so as to obtain Cchl=Ct chi and Ciani=0, wherein Ct chi is the target concentration of free macrocyclic chelate in the final liquid pharmaceutical formulation.


Find Patent Forward Citations

Loading…